Munafa Stock Market Course + Intraday & FNO calls 
Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Intellia Therapeutics (NTLA)
Technical Analysis Report for USA stock NTLA Intellia Therapeutics. Dated: 13 May 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology In Vitro In Vivo Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock NTLA Intellia Therapeutics then click here. or read Experts views on Intellia Therapeutics or Forecast & share price targets of Intellia Therapeutics
Intellia Therapeutics Opened at 13.97 and Closed at: 14.28, which is 2.03% of previous session's close. It moved within a range of 13.75 and 14.58
The session was a Bullish session with an average volume of 3757900, which is 14.71% of previous session's volumes.
- There is some positive change in the short term trend, but its too soon to jump onto conclusions.
A Dead cross was found 9 days back on short term averages
A Golden cross was found 2 days back on mid term averages
A Dead cross was found 7 days back on mid term averages
Support for tomorrow is 14.02 and resistance for tomorrow is 14.85
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 13.83, 13.37 resistance for tomorrow's hourly charts is 14.66, 15.03
10 Day SMA for Intellia Therapeutics (NTLA) is 13.86 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Intellia Therapeutics (NTLA) is 14.12 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Intellia Therapeutics (NTLA) is 13.67 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 12.81 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Intellia Therapeutics is 13.19 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Intellia Therapeutics is at 14.12 and 200 DMA is at 13.19, while 50 DMA and 100 DMA are at 13.67 and 12.81 respectively
Intellia Therapeutics (NTLA) moving average of 20 SMA is at 14.12 and 20 EMA is at 13.95
| Date | Closing Price | 20 SMA | 20 EMA |
| 13 Wed May | 14.28 | 14.12 | 13.95 |
| 12 Tue May | 13.99 | 14.11 | 13.91 |
| 11 Mon May | 14.43 | 14.16 | 13.9 |
| 08 Fri May | 14.09 | 14.17 | 13.84 |
| 07 Thu May | 13.71 | 14.18 | 13.81 |
| 06 Wed May | 13.85 | 14.17 | 13.82 |
Intellia Therapeutics (NTLA) moving average of 50 SMA is at 13.67 and 50 EMA is at 13.65
| Date | Closing Price | 50 SMA | 50 EMA |
| 13 Wed May | 14.28 | 13.67 | 13.65 |
| 12 Tue May | 13.99 | 13.69 | 13.62 |
| 11 Mon May | 14.43 | 13.69 | 13.6 |
| 08 Fri May | 14.09 | 13.69 | 13.57 |
| 07 Thu May | 13.71 | 13.67 | 13.55 |
| 06 Wed May | 13.85 | 13.67 | 13.54 |
Intellia Therapeutics (NTLA) moving average of 100 SMA is at 12.81 and 100 EMA is at 13.23
| Date | Closing Price | 100 SMA | 100 EMA |
| 13 Wed May | 14.28 | 12.81 | 13.23 |
| 12 Tue May | 13.99 | 12.75 | 13.21 |
| 11 Mon May | 14.43 | 12.7 | 13.19 |
| 08 Fri May | 14.09 | 12.65 | 13.17 |
| 07 Thu May | 13.71 | 12.6 | 13.15 |
| 06 Wed May | 13.85 | 12.56 | 13.14 |
Intellia Therapeutics (NTLA) moving average of 200 SMA is at 13.19 and 200 EMA is at 12.91
| Date | Closing Price | 200 SMA | 200 EMA |
| 13 Wed May | 14.28 | 13.19 | 12.91 |
| 12 Tue May | 13.99 | 13.19 | 12.9 |
| 11 Mon May | 14.43 | 13.18 | 12.89 |
| 08 Fri May | 14.09 | 13.18 | 12.87 |
| 07 Thu May | 13.71 | 13.18 | 12.86 |
| 06 Wed May | 13.85 | 13.17 | 12.85 |
Intellia Therapeutics has performed better than Medtronic Plc in short term. Holding Intellia Therapeutics could be a better choice for now!
Edwards Lifesciences has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Edwards Lifesciences, about 4.97% more returns!
Intellia Therapeutics has performed better than Boston Scientific in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Baxter International in short term. Holding Intellia Therapeutics could be a better choice for now!
Avanos Medical has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Avanos Medical, about 4.89% more returns!
Supernus Pharmaceuticals has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Supernus Pharmaceuticals, about 4.42% more returns!
Riot Blockchain has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Riot Blockchain, about 42.08% more returns!
Intellia Therapeutics has performed better than Repligen Corporation in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Radnet Inc in short term. Holding Intellia Therapeutics could be a better choice for now!
Ptc Therapeutics has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Ptc Therapeutics, about 5.9% more returns!
Incyte Corporation has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Incyte Corporation, about 5.5% more returns!
Establishment Labs has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Establishment Labs, about 7.46% more returns!
Intellia Therapeutics has performed better than Cytomx Therapeutics in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Celldex Therapeutics in short term. Holding Intellia Therapeutics could be a better choice for now!
Biolife Solutions has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Biolife Solutions, about 2.95% more returns!
Axsome Therapeutics has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Axsome Therapeutics, about 28.99% more returns!
Aurinia Pharmaceuticals has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Aurinia Pharmaceuticals, about 4.36% more returns!
Arrowhead Pharmaceuticals has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Arrowhead Pharmaceuticals, about 16.52% more returns!
Intellia Therapeutics has performed better than Aptorum Group in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics Technical analysis of indicators
Price action analysis of Intellia Therapeutics (NTLA) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Intellia Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Intellia Therapeutics in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Intellia Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Intellia Therapeutics in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Intellia Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 13.88 and Intellia Therapeutics NTLA stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Intellia Therapeutics NTLA stock. Volume based technical analysis of Intellia Therapeutics NTLA stock is negative.
Intellia Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock NTLA Intellia Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And NTLA Experts View which covers a lot of information including buying and selling signals
NTLA future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Intellia Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
